A Study of Comparative Advantage and Intra-Industry Trade in the Pharmaceutical Industry of Iran | Zendy

Hasan Yusefzadeh | Zendy; Aziz Rezapour | Zendy; Farhad Lotfi | Zendy; Farbod Ebadifard Azar | Zendy; Bahram Nabilo | Zendy; Hasan Abolghasem Gorji | Zendy; Mohammad Reza Hadian | Zendy; Niusha Shahidi Sadeghi | Zendy; Atiyeh Karami | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Study of Comparative Advantage and Intra-Industry Trade in the Pharmaceutical Industry of Iran

Author(s) -

Hasan Yusefzadeh,

Aziz Rezapour,

Farhad Lotfi,

Farbod Ebadifard Azar,

Bahram Nabilo,

Hasan Abolghasem Gorji,

Mohammad Reza Hadian,

Niusha Shahidi Sadeghi,

Atiyeh Karami

Publication year - 2015

Publication title -

global journal of health science

Language(s) - English

Resource type - Journals

eISSN - 1916-9744

pISSN - 1916-9736

DOI - 10.5539/gjhs.v7n6p295

Subject(s) - pharmaceutical industry , comparative advantage , revealed comparative advantage , business , international trade , order (exchange) , disadvantage , intra industry trade , world trade , drug industry , international economics , economics , trade barrier , microbiology and biotechnology , finance , political science , law , biology

Drug costs in Iran accounts for about 30% of the total health care expenditure. Moreover, pharmaceutical business lies among the world's greatest businesses. The aim of this study was to analyze Iran's comparative advantage and intra-industry trade in pharmaceuticals so that suitable policies can be developed and implemented in order to boost Iran's trade in this field.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research